Monte Rosa Therapeutics, Inc. (GLUE)

18.98 -0.18 (-0.94%) USD  |  NASDAQ  |  Feb 20, 16:00
18.99 +0.01 (+0.05%) After-Hours: 20:00
More

Monte Rosa Therapeutics Underperform Recommendations

Underperform Recommendations Chart

View Underperform Recommendations for GLUE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Underperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Underperform Recommendations Range, Past 5 Years

View Underperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Underperform Recommendations Benchmarks

View Underperform Recommendations Benchmarks
Start Trial
Amicus Therapeutics, Inc. Upgrade
Pfizer Inc. Upgrade
CorMedix, Inc. Upgrade
Zoetis, Inc. Upgrade
Alumis, Inc. Upgrade